MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy may cut needle pokes for macular degeneration patients
Disease control CompletedThis study tested whether adding a light-activated drug treatment (photodynamic therapy) to the standard injection therapy (ranibizumab) could reduce the number of injections needed for wet macular degeneration. 60 participants aged 50 and older with the condition were enrolled. …
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Texas Retina Associates • Aim: Disease control
Last updated May 26, 2026 11:31 UTC
-
New eye drops aim to control wet macular degeneration
Disease control CompletedThis study tested three different doses of SYL1801 eye drops in 99 people with wet age-related macular degeneration (AMD). The goal was to see if the drops are safe and can help maintain or improve vision. Participants received the eye drops and were followed for 42 days to measu…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Sylentis, S.A. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New drug shows promise in slowing blindness from dry AMD
Disease control CompletedThis study tested an eye injection called Zimura (avacincaptad pegol) in 448 people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes permanent vision loss. The goal was to see if the drug could slow the growth of damaged areas in the re…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: IVERIC bio, Inc. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Eye training shows promise for vision loss in macular degeneration
Knowledge-focused CompletedThis study tested new methods to measure and train eye movements in 21 people with macular degeneration and severe vision loss. Participants practiced using a different part of their retina to see, and researchers tracked changes in vision and eye movement over 14 weeks. The goal…
Matched conditions: MACULAR DEGENERATION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC